Incretin-Based Medications and Their Effects on Women's Reproductive Health: Review and Clinical Guidelines

Pregnancy concurrent with incretin-based medications is contraindicated due to unknown risk of teratogenicity.

• Incretin-based medications may pose risks during preconception and pregnancy.
• The study assessed potential benefits and risks linked to these medications in relation to maternal and neonatal health.
• Expert guidelines for clinical practice regarding the use of incretin-based medications in these contexts are proposed.
• The findings indicate a need for caution in prescribing these medications to pregnant or breastfeeding individuals.

Simplified